SECONDARY PULMONARY HYPERTENSION: SOME ASPECTS OF PATHOGENESIS
- 作者: Neklyudova G1, Avdeev S1, Tsareva N1, Chernyaev A1, Samsonova M1, Naumenko Z.1, Mikhale L2
-
隶属关系:
- Research Institute of Pulmonology
- Research Institute of Human Morphology
- 期: 卷 84, 编号 3 (2012)
- 页面: 22-28
- 栏目: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/30990
- ID: 30990
如何引用文章
全文:
详细
作者简介
G Neklyudova
Research Institute of Pulmonology
Email: Nekludova-gala@mail.ru
д-р мед. наук, ст. науч. сотр. лаб. функциональных и ультразвуковых методов исследования
S Avdeev
Research Institute of Pulmonologyд-р мед. наук, проф., зам. дир
N Tsareva
Research Institute of Pulmonologyканд. мед. наук, зав. лаб. интенсивной терапии и дыхательной недостаточности
A Chernyaev
Research Institute of Pulmonologyд-р мед. наук, проф., зав. отд. патологии
M Samsonova
Research Institute of Pulmonologyд-р мед. наук, зав. лаб. патологической анатомии и иммунологии
Zh Naumenko
Research Institute of Pulmonologyканд. мед. наук, ст. науч. сотр. лаб. функциональных и ультразвуковых методов исследования
L Mikhale
Research Institute of Human Morphologyд-р мед. наук, проф., акад. РАЕН, зав. лаб. клинической морфологии УРАМН НИИ морфологии человека РАМН
参考
- Weitzenblum E., Hirth C., Ducolone A. et al. Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax 1981; 36: 752—758.
- Kessler R., Faller M., Fourgaut G. et al. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1999; 159 (1): 158—164.
- Nathan S. D., Noble P. W., Tuder R. M. Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots. Am. J. Respir. Crit. Care Med. 2007; 175 (9): 875—880.
- Rubin L. J. Primary pulmonary hypertension. Chest 1993; 104 (1): 236—250.
- Замотаев И. П. Легочно-сердечная недостаточность. М.: Медицина; 1978: 200.
- Weitzenblum E., Sautegeau A., Ehrrhart M. et al. Long-term course of pulmonary arterial pressure in patients with chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 1984; 130: 993—998.
- Ландышева И. В. Хроническое легочное сердце. Благовещенск; 1980: 173.
- Nakamura A., Kasamatsu N., Hashizume I. et al. Effects of hemoglobin on pulmonary arterial pressure and pulmonary vascular resistance in patients with chronic emphysema. Respiration 2000; 67: 502—506.
- Dinh-Xuan A. T., Higgenbottam T. W., Clelland C. A. et al. Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. N. Engl. J. Med. 1991; 324: 1539—1547.
- Galie N., Rubin L. J. et al. Pulmonary Arterial Hypertension: epidemiology, pathobiology, assessment, and therapy. J. Am. Coll. Cardiol. 2004; 12: 5S—12S.
- Ignarro L. J. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ. Res. 1989; 65: 1—21.
- Global Strategy for Diagnosis, Management, and Prevention of COPD (updated 2009). www.goldcopd.org.
- American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment; international consensus statement — American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am. J. Respir. Crit. Care Med. 2000; 161: 646—664.
- American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am. J. Respir. Crit. Care Med. 2002; 165: 277—304.
- Hart C. M. Nitric oxide in adult lung disease. Chest 1999; 115: 1407—1417.
- Yoshida M., Taguchi O., Gabazza E. C. et al. The effect of low-dose inchalation of nitric oxide in patients with pulmonary fibrosis. Eur. Respir. J. 1997; 10: 2051—2054.
- Quanjer Ph. H., Tammeling G., Cotes J. E. et al. Lung volumes and forced ventilatory flows. Eur. Respir. J. 1993; 6 (suppl. 16): 5—40.
- Berger M., Haimovitz A., Van Tosh A. et al. Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. J. Am. Coll. Cardiol. 1985; 6: 359—365.
- Kircher B., Himelman R. B., Schiller M. B. Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am. J. Cardiol. 1990; 15; 66 (4): 493—496.
- Автандилов Г. Г. Морфометрия в патологии. М.: Медицина; 1973: 248.
- Germann P., Braschi A., Della Rocca G. et al. Inhaled nitric oxide therapy in adults: European expert recommendations. Intensive Care Med. 2005; 31: 1029--1041.
- Siobal M. Aerosolized Prostacyclins. Respir. Care. 2004; 49: 640—652.
- Snider G. L., Fairley H. B., Palmer J. D., Weg J. C. Scientific basis of oxygen therapy. Chest 1984; 86: 236—239.
- O’Driscoll B. R., Howard L. S., Davison A. G. British Thoracic Society. BTS guideline for emergency oxygen use in adult patients. Thorax 2008; 63 (Suppl. VI): vi1--vi68.
- Galie’ N., Hoeper M. M., Humbert M. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur. Heart J. 2009; 30: 2493—2537.
- Von Euler U., Lijestrand G. Observations on the pulmonary arterial blood pressure in cat. Acta Physiol. Scand. 1946; 12: 301—320.
- Scharf S. M., Iqbal M., Keller C. et al. Hemodynamic characterization of patients with severe emphysema. Am. J. Respir. Crit. Care Med. 2002; 166: 314—322.
- Doi M., Nakano K., Hiramoto T., Kohno N. Significance of pulmonary artery pressure in emphysema patienys with mild-to-moderate hypoxemia. Respir. Med. 2003; 97 (8): 915—920.
- Naeije R., MacNee W. Pulmonary circulation. In: Calverley P., MacNee W., Pride P., Rennard S., eds. Chronic obstructive pulmonary disease, 2nd ed. London: Arnold Health Sciences; 2003: 228—242.
- Nathan S., Shlobin O., Ahmad S. et al. Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis. Chest 2007; 131: 657—663.
- Hamada K., Nagai S., Tanaka S. et al. Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest 2007; 131 (3): 650—656.
- Welte M., Zwissler B., Habazettl H., Messmer K. PGI2 aerosol versus nitic oxide for selective pulmonary vasodilation in hypoxic pulmonary vasoconstriction. Eur. Surg. Res. 1993; 25: 329—340.
- Kouyoumdjian C., Adnot S., Levame M. et al. Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic rats. J. Clin. Invest. 1994; 94: 578—584.
- Badesch D. B., Abman S. H., Ahearn G. S. et al. American College of Chest Physicians. Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004; 126 (1, Suppl): 35S—62S.
- Le Cras T. D., McMurtry I. F Nitric oxide production in the hypoxic lung. Am. J. Physiol. Lung Cell Mol. Physiol. 2001; 280 (4): L575— L582.
- Carratu P., Scoditti C., Maniscalco M. et al. Exhaled and arterial levels of endothelin-1 are increased and correlate with pulmonary systolic pressure in COPD with pulmonary hypertension. BMC Pulm. Med. 2008; 8: 20.
- Trakada G., Nikolaou E., Pouli A. et al. Endothelin-1 levels in interstitial lung disease patients during sleep. Sleep Breath 2003; 7 (3): 111—118.
- Shen Q., Chen P., Yang M. et al. The expression of prostacyclin in lung from patients with chronic obstructive pulmonary disease. Zhonghua Jie He He Hu Xi Za Zhi 2010; 33 (2): 114—117.
- Santos S., Peinado V. I., Ramirez J. et al. Characterization of pulmonary vascular remodelling in smokers and patients whith mild COPD. Eur. Respir. J. 2002; 19: 632—638.
- Barbera J. A., Blanco I. Pulmonary hypertension in patients with chronic obstructive pulmonary disease: advances in pathophysiology and management. Drugs 2009; 69 (9): 1153—1171.